Clinical Trial: CMTS4520 for Chronic Diarrhoea in Adults

U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06839586) titled 'CMTS4520 for Chronic Diarrhoea in Adults' on Feb. 14.

Brief Summary: This is a randomized controlled trial to explore the efficacy and safety of CMTS4520 (Dietary Fiber Probiotics) for patients with chronic diarrhoea.

Study Start Date: Feb. 20

Study Type: INTERVENTIONAL

Condition: Diarrhoea

Intervention: DRUG: CMTS4520 (dietary fiber and probiotics)

CMTS4520 is a synbiotic formulation containing a standardized ratio of plant-derived prebiotics and clinically validated probiotic strains. Participants will receive 4 weeks of CMTS4520 daily for chronic diarrhoea.

DRUG: Placebo

Capsules with matching volume and consistent appea...